These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The Association Between Plasma Ceramides and Sphingomyelins and Risk of Alzheimer's Disease Differs by Sex and APOE in the Baltimore Longitudinal Study of Aging. Mielke MM; Haughey NJ; Han D; An Y; Bandaru VVR; Lyketsos CG; Ferrucci L; Resnick SM J Alzheimers Dis; 2017; 60(3):819-828. PubMed ID: 28035934 [TBL] [Abstract][Full Text] [Related]
4. Serum sphingomyelins and ceramides are early predictors of memory impairment. Mielke MM; Bandaru VV; Haughey NJ; Rabins PV; Lyketsos CG; Carlson MC Neurobiol Aging; 2010 Jan; 31(1):17-24. PubMed ID: 18455839 [TBL] [Abstract][Full Text] [Related]
5. Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss. Mielke MM; Haughey NJ; Bandaru VV; Schech S; Carrick R; Carlson MC; Mori S; Miller MI; Ceritoglu C; Brown T; Albert M; Lyketsos CG Alzheimers Dement; 2010 Sep; 6(5):378-85. PubMed ID: 20813340 [TBL] [Abstract][Full Text] [Related]
6. Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort study. Schilling S; Tzourio C; Soumaré A; Kaffashian S; Dartigues JF; Ancelin ML; Samieri C; Dufouil C; Debette S PLoS Med; 2017 Mar; 14(3):e1002265. PubMed ID: 28350817 [TBL] [Abstract][Full Text] [Related]